Thompson Davis & CO. Inc. Has $1.37 Million Stock Holdings in Profound Medical Corp. (NASDAQ:PROF)

Thompson Davis & CO. Inc. raised its position in Profound Medical Corp. (NASDAQ:PROF) by 78.9% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 182,295 shares of the company’s stock after purchasing an additional 80,395 shares during the period. Profound Medical accounts for approximately 0.9% of Thompson Davis & CO. Inc.’s portfolio, making the stock its 11th largest position. Thompson Davis & CO. Inc. owned 0.61% of Profound Medical worth $1,369,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Gagnon Securities LLC lifted its position in shares of Profound Medical by 12.6% in the 4th quarter. Gagnon Securities LLC now owns 1,652,531 shares of the company’s stock worth $12,411,000 after purchasing an additional 185,284 shares during the period. Gagnon Advisors LLC lifted its position in shares of Profound Medical by 20.0% in the 4th quarter. Gagnon Advisors LLC now owns 896,671 shares of the company’s stock worth $6,734,000 after purchasing an additional 149,445 shares during the period. Royce & Associates LP increased its stake in shares of Profound Medical by 0.6% in the 3rd quarter. Royce & Associates LP now owns 569,298 shares of the company’s stock valued at $4,529,000 after acquiring an additional 3,500 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Profound Medical in the 3rd quarter valued at $612,000. Finally, K2 Principal Fund L.P. bought a new stake in shares of Profound Medical in the 3rd quarter valued at $398,000. Institutional investors and hedge funds own 47.86% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Raymond James upgraded shares of Profound Medical to a “strong-buy” rating in a research note on Saturday, November 9th.

Profound Medical Trading Up 0.5 %

NASDAQ:PROF opened at $7.48 on Friday. The company has a fifty day moving average of $7.01 and a 200-day moving average of $7.74. The company has a current ratio of 6.12, a quick ratio of 5.16 and a debt-to-equity ratio of 0.11. Profound Medical Corp. has a twelve month low of $5.63 and a twelve month high of $11.42.

Profound Medical Company Profile

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.